These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32216447)

  • 1. Lung Tissue Damage Associated with Allergic Asthma in BALB/c Mice Could Be Controlled with a Single Injection of Mesenchymal Stem Cells from Human Bone Marrow up to 14 d After Transplantation.
    Boldrini-Leite LM; Michelotto PV; de Moura SAB; Capriglione LGA; Barussi FCM; Fragoso FYI; Senegaglia AC; Brofman PRS
    Cell Transplant; 2020; 29():963689720913254. PubMed ID: 32216447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma.
    Abreu SC; Lopes-Pacheco M; da Silva AL; Xisto DG; de Oliveira TB; Kitoko JZ; de Castro LL; Amorim NR; Martins V; Silva LHA; Gonçalves-de-Albuquerque CF; de Castro Faria-Neto HC; Olsen PC; Weiss DJ; Morales MM; Diaz BL; Rocco PRM
    Front Immunol; 2018; 9():1147. PubMed ID: 29881388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum from Asthmatic Mice Potentiates the Therapeutic Effects of Mesenchymal Stromal Cells in Experimental Allergic Asthma.
    Abreu SC; Xisto DG; de Oliveira TB; Blanco NG; de Castro LL; Kitoko JZ; Olsen PC; Lopes-Pacheco M; Morales MM; Weiss DJ; Rocco PRM
    Stem Cells Transl Med; 2019 Mar; 8(3):301-312. PubMed ID: 30426724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of human mesenchymal stem cells on airway inflammation in allergic asthma mice and the underlying mechanism].
    Ren NN; Chen HJ; Chen QL; Eileen J; An YG; Lin Y
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2697-2702. PubMed ID: 28910960
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma.
    Kitoko JZ; de Castro LL; Nascimento AP; Abreu SC; Cruz FF; Arantes AC; Xisto DG; Martins MA; Morales MM; Rocco PRM; Olsen PC
    Clin Exp Allergy; 2018 Feb; 48(2):205-216. PubMed ID: 29068567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells overexpressing interleukin-10 prevent allergic airway inflammation.
    Kuang PP; Liu XQ; Li CG; He BX; Xie YC; Wu ZC; Li CL; Deng XH; Fu QL
    Stem Cell Res Ther; 2023 Dec; 14(1):369. PubMed ID: 38093354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Marrow, Adipose, and Lung Tissue-Derived Murine Mesenchymal Stromal Cells Release Different Mediators and Differentially Affect Airway and Lung Parenchyma in Experimental Asthma.
    Abreu SC; Antunes MA; Xisto DG; Cruz FF; Branco VC; Bandeira E; Zola Kitoko J; de Araújo AF; Dellatorre-Texeira L; Olsen PC; Weiss DJ; Diaz BL; Morales MM; Rocco PRM
    Stem Cells Transl Med; 2017 Jun; 6(6):1557-1567. PubMed ID: 28425576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Human MSCs Treatment Frequency on Airway Inflammation in a Mouse Model of Acute Asthma.
    Hur J; Kang JY; Kim YK; Lee SY; Jeon S; Kim Y; Jung CK; Rhee CK
    J Korean Med Sci; 2020 Jun; 35(23):e188. PubMed ID: 32537953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of mycobacterial Ag85A and IL-17A fusion protein attenuates airway inflammation in a murine model of asthma.
    Jin R; Guo S; Wang MY; Li YH; Wu LX; Ma H; Lowrie DB; Fan XY; Zhang JH
    Int Immunopharmacol; 2013 Dec; 17(4):1067-74. PubMed ID: 24455775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model.
    Urbanek K; De Angelis A; Spaziano G; Piegari E; Matteis M; Cappetta D; Esposito G; Russo R; Tartaglione G; De Palma R; Rossi F; D'Agostino B
    PLoS One; 2016; 11(7):e0158746. PubMed ID: 27434719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Effects of Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on a Murine Model of Acute Type-2-Dominated Airway Inflammation.
    Ma SY; Zhao N; Cui L; Li Y; Zhang H; Wang J; Pang J; Wang M; Wang C; Ying S; Jin ZB; Zhang L
    Stem Cell Rev Rep; 2022 Dec; 18(8):2939-2951. PubMed ID: 35622293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice.
    Dong L; Wang Y; Zheng T; Pu Y; Ma Y; Qi X; Zhang W; Xue F; Shan Z; Liu J; Wang X; Mao C
    Stem Cell Res Ther; 2021 Jan; 12(1):4. PubMed ID: 33407872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilodendron bipinnatum Radlk. ameliorates airway inflammation through multiple targets in a murine model of ovalbumin-induced allergic airway disease.
    de Oliveira RG; Miyajima F; Castilho GRC; Damazo AS; Macho A; Martins DTO
    J Ethnopharmacol; 2018 Nov; 226():17-25. PubMed ID: 30053531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice.
    Sun YQ; Deng MX; He J; Zeng QX; Wen W; Wong DS; Tse HF; Xu G; Lian Q; Shi J; Fu QL
    Stem Cells; 2012 Dec; 30(12):2692-9. PubMed ID: 22987325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epimedin C modulates the balance between Th9 cells and Treg cells through negative regulation of noncanonical NF-κB pathway and MAPKs activation to inhibit airway inflammation in the ovalbumin-induced murine asthma model.
    Huang M; Wei Y; Dong J
    Pulm Pharmacol Ther; 2020 Dec; 65():102005. PubMed ID: 33636365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupleurum chinense extract ameliorates an OVA-induced murine allergic asthma through the reduction of the Th2 and Th17 cytokines production by inactivation of NFκB pathway.
    Bui TT; Piao CH; Song CH; Shin HS; Chai OH
    Biomed Pharmacother; 2017 Jul; 91():1085-1095. PubMed ID: 28531919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharides promote a shift from Th2-derived airway eosinophilic inflammation to Th17-derived neutrophilic inflammation in an ovalbumin-sensitized murine asthma model.
    Zhao S; Jiang Y; Yang X; Guo D; Wang Y; Wang J; Wang R; Wang C
    J Asthma; 2017 Jun; 54(5):447-455. PubMed ID: 27589490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model.
    Wei Y; Luo QL; Sun J; Chen MX; Liu F; Dong JC
    J Ethnopharmacol; 2015 Apr; 164():368-77. PubMed ID: 25625352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxopyrum serratulum ameliorates airway inflammation in LPS-stimulated RAW 264.7 macrophages and OVA-induced murine model of allergic asthma.
    Maruthamuthu V; Henry LJK; Ramar MK; Kandasamy R
    J Ethnopharmacol; 2020 Jun; 255():112369. PubMed ID: 31683035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.